Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
Public ClinicalTrials.gov record NCT00875238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Predicting Adverse Cardiac Events in Breast Cancer Therapy (PACE in Breast Cancer)
Study identification
- NCT ID
- NCT00875238
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Vanderbilt University
- Other
- Enrollment
- 133 participants
Conditions and interventions
Interventions
- assessment of therapy complications Procedure
- doxorubicin hydrochloride Drug
- laboratory biomarker analysis Other
- magnetic resonance imaging Procedure
- polymorphism analysis Genetic
- questionnaire administration Other
- trastuzumab Biological
Procedure · Drug · Other + 2 more
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2008
- Primary completion
- Feb 28, 2015
- Completion
- Feb 28, 2015
- Last update posted
- Feb 18, 2018
2008 – 2015
United States locations
- U.S. sites
- 4
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Louisville James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| Vanderbilt Heart One Hundred Oaks | Nashville | Tennessee | 37204 | — |
| MBCCOP - Meharry Medical College - Nashville | Nashville | Tennessee | 37208 | — |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232-6838 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00875238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2018 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00875238 live on ClinicalTrials.gov.